Decreased Bioavailability of Rifampin and Other Antituberculosis Drugs in Patients with Advanced Human Immunodeficiency Virus Disease
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...
Gespeichert in:
Veröffentlicht in: | Antimicrobial Agents and Chemotherapy 2004-11, Vol.48 (11), p.4473-4475 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 4475 |
---|---|
container_issue | 11 |
container_start_page | 4473 |
container_title | Antimicrobial Agents and Chemotherapy |
container_volume | 48 |
creator | GURUMURTHY, Prema RAMACHANDRAN, Geetha RAVICHANDRAN, N PARAMESH, P HEMANTH KUMAR, A. K RAJASEKARAN, S PADMAPRIYADARSINI, C SWAMINATHAN, Soumya BHAGAVATHY, S VENKATESAN, P SEKAR, L MAHILMARAN, A |
description | Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
|
doi_str_mv | 10.1128/AAC.48.11.4473-4475.2004 |
format | Article |
fullrecord | <record><control><sourceid>proquest_asm2_</sourceid><recordid>TN_cdi_proquest_miscellaneous_17714410</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67005219</sourcerecordid><originalsourceid>FETCH-LOGICAL-a574t-f9d91d63a2426ada6e0d2a7689448eba29aba30efc391f1405bc85b6d650ac7b3</originalsourceid><addsrcrecordid>eNqNksFu1DAQhiMEokvhFZCFBLcstmM7zoFDugVaqVIRAq7WxHY2rpJ4sZOt9gF4bxztipYTXMZj-ftnRvM7yxDBa0KofF_XmzWTKV8zVhZ5CnxNMWZPshXBlcwFr8TTbIWxEDmTmJ1lL2K8w-nOK_w8OyOcYyZlucp-XVodLERr0IXzsAfXQ-N6Nx2Qb9FX18KwcyOC0aDbqbMB1ePkprmxQc-9jy6iyzBvI0rMF5icHaeI7t3UodrsYdSp7NU8wIiuh2EevbGt0wnSB_TDhTmJXVyav8yetdBH--p0nmffP338trnKb24_X2_qmxx4yaa8rUxFjCiAMirAgLDYUCiFrBiTtgFaQQMFtq0uKtIShnmjJW-EERyDLpviPPtwrLubm8EancYN0KtdcAOEg_Lg1N8vo-vU1u8Vp5wVVdK_O-mD_znbOKnBRW37Hkbr56hEiTGn5N8gKUvCGMEJlEdQBx9jsO2fYQhWi9cqea2YTLlavF4CV4vXScqPUogDVXd-DmPa3f_oXj9ewkPD06dIwNsTAFFD34ZkpIsPnKCCk4Im7s2R69y2u3fBqjSJAtCP-ha_AdWh0Q8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17714410</pqid></control><display><type>article</type><title>Decreased Bioavailability of Rifampin and Other Antituberculosis Drugs in Patients with Advanced Human Immunodeficiency Virus Disease</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>GURUMURTHY, Prema ; RAMACHANDRAN, Geetha ; RAVICHANDRAN, N ; PARAMESH, P ; HEMANTH KUMAR, A. K ; RAJASEKARAN, S ; PADMAPRIYADARSINI, C ; SWAMINATHAN, Soumya ; BHAGAVATHY, S ; VENKATESAN, P ; SEKAR, L ; MAHILMARAN, A</creator><creatorcontrib>GURUMURTHY, Prema ; RAMACHANDRAN, Geetha ; RAVICHANDRAN, N ; PARAMESH, P ; HEMANTH KUMAR, A. K ; RAJASEKARAN, S ; PADMAPRIYADARSINI, C ; SWAMINATHAN, Soumya ; BHAGAVATHY, S ; VENKATESAN, P ; SEKAR, L ; MAHILMARAN, A</creatorcontrib><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.48.11.4473-4475.2004</identifier><identifier>PMID: 15504887</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Acetylation ; Adult ; Antibiotics, Antitubercular ; Antibiotics, Antitubercular - pharmacokinetics ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antitubercular Agents - pharmacokinetics ; Biological and medical sciences ; Biological Availability ; Ethambutol - pharmacokinetics ; Feces - microbiology ; Female ; HIV Infections ; HIV Infections - complications ; HIV Infections - metabolism ; Human immunodeficiency virus ; Humans ; Intestinal Absorption ; Isoniazid - pharmacokinetics ; Male ; Medical sciences ; Middle Aged ; Pharmacology ; Pharmacology. Drug treatments ; Phenotype ; Pyrazinamide - pharmacokinetics ; Rifampin ; Rifampin - pharmacokinetics ; Tuberculosis - complications ; Tuberculosis - metabolism</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2004-11, Vol.48 (11), p.4473-4475</ispartof><rights>2005 INIST-CNRS</rights><rights>Copyright © 2004 American Society for Microbiology</rights><rights>Copyright © 2004, American Society for Microbiology 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a574t-f9d91d63a2426ada6e0d2a7689448eba29aba30efc391f1405bc85b6d650ac7b3</citedby><cites>FETCH-LOGICAL-a574t-f9d91d63a2426ada6e0d2a7689448eba29aba30efc391f1405bc85b6d650ac7b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC525439/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC525439/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16265132$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15504887$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GURUMURTHY, Prema</creatorcontrib><creatorcontrib>RAMACHANDRAN, Geetha</creatorcontrib><creatorcontrib>RAVICHANDRAN, N</creatorcontrib><creatorcontrib>PARAMESH, P</creatorcontrib><creatorcontrib>HEMANTH KUMAR, A. K</creatorcontrib><creatorcontrib>RAJASEKARAN, S</creatorcontrib><creatorcontrib>PADMAPRIYADARSINI, C</creatorcontrib><creatorcontrib>SWAMINATHAN, Soumya</creatorcontrib><creatorcontrib>BHAGAVATHY, S</creatorcontrib><creatorcontrib>VENKATESAN, P</creatorcontrib><creatorcontrib>SEKAR, L</creatorcontrib><creatorcontrib>MAHILMARAN, A</creatorcontrib><title>Decreased Bioavailability of Rifampin and Other Antituberculosis Drugs in Patients with Advanced Human Immunodeficiency Virus Disease</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>AAC</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><subject>Acetylation</subject><subject>Adult</subject><subject>Antibiotics, Antitubercular</subject><subject>Antibiotics, Antitubercular - pharmacokinetics</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antitubercular Agents - pharmacokinetics</subject><subject>Biological and medical sciences</subject><subject>Biological Availability</subject><subject>Ethambutol - pharmacokinetics</subject><subject>Feces - microbiology</subject><subject>Female</subject><subject>HIV Infections</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - metabolism</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Intestinal Absorption</subject><subject>Isoniazid - pharmacokinetics</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Phenotype</subject><subject>Pyrazinamide - pharmacokinetics</subject><subject>Rifampin</subject><subject>Rifampin - pharmacokinetics</subject><subject>Tuberculosis - complications</subject><subject>Tuberculosis - metabolism</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNksFu1DAQhiMEokvhFZCFBLcstmM7zoFDugVaqVIRAq7WxHY2rpJ4sZOt9gF4bxztipYTXMZj-ftnRvM7yxDBa0KofF_XmzWTKV8zVhZ5CnxNMWZPshXBlcwFr8TTbIWxEDmTmJ1lL2K8w-nOK_w8OyOcYyZlucp-XVodLERr0IXzsAfXQ-N6Nx2Qb9FX18KwcyOC0aDbqbMB1ePkprmxQc-9jy6iyzBvI0rMF5icHaeI7t3UodrsYdSp7NU8wIiuh2EevbGt0wnSB_TDhTmJXVyav8yetdBH--p0nmffP338trnKb24_X2_qmxx4yaa8rUxFjCiAMirAgLDYUCiFrBiTtgFaQQMFtq0uKtIShnmjJW-EERyDLpviPPtwrLubm8EancYN0KtdcAOEg_Lg1N8vo-vU1u8Vp5wVVdK_O-mD_znbOKnBRW37Hkbr56hEiTGn5N8gKUvCGMEJlEdQBx9jsO2fYQhWi9cqea2YTLlavF4CV4vXScqPUogDVXd-DmPa3f_oXj9ewkPD06dIwNsTAFFD34ZkpIsPnKCCk4Im7s2R69y2u3fBqjSJAtCP-ha_AdWh0Q8</recordid><startdate>20041101</startdate><enddate>20041101</enddate><creator>GURUMURTHY, Prema</creator><creator>RAMACHANDRAN, Geetha</creator><creator>RAVICHANDRAN, N</creator><creator>PARAMESH, P</creator><creator>HEMANTH KUMAR, A. K</creator><creator>RAJASEKARAN, S</creator><creator>PADMAPRIYADARSINI, C</creator><creator>SWAMINATHAN, Soumya</creator><creator>BHAGAVATHY, S</creator><creator>VENKATESAN, P</creator><creator>SEKAR, L</creator><creator>MAHILMARAN, A</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20041101</creationdate><title>Decreased Bioavailability of Rifampin and Other Antituberculosis Drugs in Patients with Advanced Human Immunodeficiency Virus Disease</title><author>GURUMURTHY, Prema ; RAMACHANDRAN, Geetha ; RAVICHANDRAN, N ; PARAMESH, P ; HEMANTH KUMAR, A. K ; RAJASEKARAN, S ; PADMAPRIYADARSINI, C ; SWAMINATHAN, Soumya ; BHAGAVATHY, S ; VENKATESAN, P ; SEKAR, L ; MAHILMARAN, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a574t-f9d91d63a2426ada6e0d2a7689448eba29aba30efc391f1405bc85b6d650ac7b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Acetylation</topic><topic>Adult</topic><topic>Antibiotics, Antitubercular</topic><topic>Antibiotics, Antitubercular - pharmacokinetics</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antitubercular Agents - pharmacokinetics</topic><topic>Biological and medical sciences</topic><topic>Biological Availability</topic><topic>Ethambutol - pharmacokinetics</topic><topic>Feces - microbiology</topic><topic>Female</topic><topic>HIV Infections</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - metabolism</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Intestinal Absorption</topic><topic>Isoniazid - pharmacokinetics</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Phenotype</topic><topic>Pyrazinamide - pharmacokinetics</topic><topic>Rifampin</topic><topic>Rifampin - pharmacokinetics</topic><topic>Tuberculosis - complications</topic><topic>Tuberculosis - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GURUMURTHY, Prema</creatorcontrib><creatorcontrib>RAMACHANDRAN, Geetha</creatorcontrib><creatorcontrib>RAVICHANDRAN, N</creatorcontrib><creatorcontrib>PARAMESH, P</creatorcontrib><creatorcontrib>HEMANTH KUMAR, A. K</creatorcontrib><creatorcontrib>RAJASEKARAN, S</creatorcontrib><creatorcontrib>PADMAPRIYADARSINI, C</creatorcontrib><creatorcontrib>SWAMINATHAN, Soumya</creatorcontrib><creatorcontrib>BHAGAVATHY, S</creatorcontrib><creatorcontrib>VENKATESAN, P</creatorcontrib><creatorcontrib>SEKAR, L</creatorcontrib><creatorcontrib>MAHILMARAN, A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GURUMURTHY, Prema</au><au>RAMACHANDRAN, Geetha</au><au>RAVICHANDRAN, N</au><au>PARAMESH, P</au><au>HEMANTH KUMAR, A. K</au><au>RAJASEKARAN, S</au><au>PADMAPRIYADARSINI, C</au><au>SWAMINATHAN, Soumya</au><au>BHAGAVATHY, S</au><au>VENKATESAN, P</au><au>SEKAR, L</au><au>MAHILMARAN, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decreased Bioavailability of Rifampin and Other Antituberculosis Drugs in Patients with Advanced Human Immunodeficiency Virus Disease</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>AAC</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2004-11-01</date><risdate>2004</risdate><volume>48</volume><issue>11</issue><spage>4473</spage><epage>4475</epage><pages>4473-4475</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>15504887</pmid><doi>10.1128/AAC.48.11.4473-4475.2004</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0066-4804 |
ispartof | Antimicrobial Agents and Chemotherapy, 2004-11, Vol.48 (11), p.4473-4475 |
issn | 0066-4804 1098-6596 |
language | eng |
recordid | cdi_proquest_miscellaneous_17714410 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Acetylation Adult Antibiotics, Antitubercular Antibiotics, Antitubercular - pharmacokinetics Antibiotics. Antiinfectious agents. Antiparasitic agents Antitubercular Agents - pharmacokinetics Biological and medical sciences Biological Availability Ethambutol - pharmacokinetics Feces - microbiology Female HIV Infections HIV Infections - complications HIV Infections - metabolism Human immunodeficiency virus Humans Intestinal Absorption Isoniazid - pharmacokinetics Male Medical sciences Middle Aged Pharmacology Pharmacology. Drug treatments Phenotype Pyrazinamide - pharmacokinetics Rifampin Rifampin - pharmacokinetics Tuberculosis - complications Tuberculosis - metabolism |
title | Decreased Bioavailability of Rifampin and Other Antituberculosis Drugs in Patients with Advanced Human Immunodeficiency Virus Disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T04%3A52%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_asm2_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decreased%20Bioavailability%20of%20Rifampin%20and%20Other%20Antituberculosis%20Drugs%20in%20Patients%20with%20Advanced%20Human%20Immunodeficiency%20Virus%20Disease&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=GURUMURTHY,%20Prema&rft.date=2004-11-01&rft.volume=48&rft.issue=11&rft.spage=4473&rft.epage=4475&rft.pages=4473-4475&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.48.11.4473-4475.2004&rft_dat=%3Cproquest_asm2_%3E67005219%3C/proquest_asm2_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17714410&rft_id=info:pmid/15504887&rfr_iscdi=true |